The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist

MeSH terms

• Animals
• Antineoplastic Agents / therapeutic use*
• Biological Transport
• Carcinoma 256, Walker / drug therapy*
• Carcinoma 256, Walker / enzymology
• Carcinoma 256, Walker / metabolism
• DNA, Neoplasm / biosynthesis
• Deoxyuridine / metabolism
• Folic Acid Antagonists / metabolism
• Folic Acid Antagonists / therapeutic use*
• In Vitro Techniques
• Leukemia L1210 / drug therapy*
• Leukemia L1210 / enzymology
• Leukemia L1210 / metabolism
• Methotrexate / pharmacology
• Mice
• Rats
• Tetrahydrofolate Dehydrogenase / metabolism
• Triazines / metabolism
• Triazines / therapeutic use*
• Tritium